Skip to main content
SpringerLink
Log in

ASO Author Reflections: Factors that Predict Performance of Sentinel Lymph Node Biopsy and the Association with Improved Survival for Melanoma Patients Who Have Nodal Staging

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Wong SL, Faries MB, Kennedy EB, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36:399–413.

    Article  PubMed  Google Scholar 

  3. Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211–22.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy-positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17:757–67.

    Article  PubMed  Google Scholar 

  5. Murtha TD, Han G, Han D. Predictors for use of sentinel node biopsy and the association with improved survival in melanoma patients who have nodal staging. Ann Surg Oncol. 2018;25:903–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Surgical Oncology, Department of Surgery, Yale School of Medicine, New Haven, CT, USA

    Timothy D. Murtha MD, MHS

  2. Division of Surgical Oncology, Department of Surgery, Oregon Health and Science University, Portland, OR, USA

    Dale Han MD, FACS

Authors
  1. Timothy D. Murtha MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dale Han MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dale Han MD, FACS.

Ethics declarations

Disclosure

The authors have no conflict of interest to disclose

Additional information

ASO Author Reflections is a brief invited commentary on the article, “Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging,” Ann Surg Oncol. 2018; 25:903–911.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murtha, T.D., Han, D. ASO Author Reflections: Factors that Predict Performance of Sentinel Lymph Node Biopsy and the Association with Improved Survival for Melanoma Patients Who Have Nodal Staging. Ann Surg Oncol 25 (Suppl 3), 904–905 (2018). https://doi.org/10.1245/s10434-018-6841-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6841-7

Keywords

Search

Navigation